61 search results for the keyword shortage notice in

Show filters
Sort by

Narrow your results

Latest News

Medicine Supply Notification: Bupropion (Zyban®) 150mg modified-release tablets

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Bupropion (Zyban®) 150mg modified-release tablets. MSN/2022/100 Tier 3 – high impact Date of issue 1st December 2022 Bupropion (Zyban®) 150mg modified-release tablets will be out of [...]

Published on: 1st December 2022 | Updated on: 1st December 2022

Latest News

Medicine Supply Notification: Prochlorperazine (Stemetil®) 5mg/5ml Syrup

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Prochlorperazine (Stemetil®) 5mg/5ml Syrup. MSN/2022/085 Tier 2 – medium impact Date of issue 12th October 2022 All batches of Stemetil 5mg/5ml Syrup have been recalled as [...]

Published on: 12th October 2022 | Updated on: 12th October 2022

Latest News

Medicine Supply Notification: Paracetamol 120mg and 240mg suppositories

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Paracetamol 120mg and 240mg suppositories. MSN/2022/003 Tier 2 – medium impact Date of issue 26th January 2022 Paracetamol 120mg and 240mg suppositories are out of stock [...]

Published on: 26th January 2022 | Updated on: 26th January 2022

Latest News

Supply disruption alert: Champix (Varenicline) 0.5mg and 1mg tablets – Pfizer – Updated

SDA/2021/006 (U) this update supercedes the advice provided in the previous alert SDA/2021/006 Date issued 28th October 2021 Champix® (varenicline) 0.5mg and 1mg tablets – Supply Disruption All Champix® (varenicline) products are unavailable until further notice. The Medicines and Healthcare [...]

Published on: 29th October 2021 | Updated on: 29th October 2021

Pages

Community Pharmacy IT Group (CP ITG) workstream updates (archive)

Read more about CP ITG and its work at: the Community Pharmacy IT Group (CP ITG) webpage. This ‘CP ITG workstream update (archive)‘ webpage sets out information following past CP ITG meetings based on past pharmacy IT bulletin. The bulletins [...]

Published on: 4th October 2021 | Updated on: 19th October 2023

Latest News

MHRA Class 2 Medicines Recall: Irbesartan-containing products – Updated

Updated: 16/08/21 – the expiry date  for Aprovel 150mg tablets batch 0R855 should be April 2023  MHRA Class 2 Medicines Recall: Irbesartan-containing products Drug alert number: EL (21)A/19 MDR Number: MDR 050-10/20 Date issued: 5th August 2021 The Medicines and [...]

Published on: 16th August 2021 | Updated on: 18th July 2022

Latest News

MHRA Class 2 Medicines Recall: Irbesartan and Losartan containing products

MHRA Class 2 Medicines Recall: Bristol Laboratories Limited, Brown & Burk UK Ltd, Teva UK Ltd, Irbesartan-containing and Losartan-containing products Drug alert number: EL (21)A/14 MDR Number: MDR 015-05/21 Date issued: 17th June 2021 The Medicines and Healthcare products Regulatory [...]

Published on: 17th June 2021 | Updated on: 17th June 2021

Latest News

Medicine Supply Notification: Ranitidine all formulations – Update

Update: 31.03.2021  All preparations of ranitidine (tablets, effervescent tablets, oral solution and injection) are out of stock until further notice. Following recent advice from the EMA, the MHRA have suspended all licenses for ranitidine products. Department of Health and Social Care [...]

Published on: 31st March 2021 | Updated on: 6th May 2022

Pages

Information & Disclosure Regulations

The Department of Health and Social Care (DHSC) has greater powers to request information about the prices and costs associated with products purchased for the NHS. The Health Service Products (Provision and Disclosure of Information) Regulations 2018 (the Regulations) came into [...]

Published on: 8th August 2018 | Updated on: 15th March 2022

Pages

Patient safety information

The Medicines and Healthcare products Regulatory Agency (MHRA) have made changes to the way they issue drug safety messaging to healthcare providers. MHRA Drug Alerts have been renamed, drug safety notices will no longer be referred to as ‘Drug alerts’ [...]

Published on: 27th July 2017 | Updated on: 10th April 2024

Pages

Smartcard multi-site and SCR arrangements

Pharmacy team members use NHS Smartcards to access NHS IT such as EPS and Summary Care Records (SCR). The Smartcard model sets out that Local Registration Authorities (RAs) prepare or update Smartcards for pharmacy team members by applying (or ‘linking’) [...]

Published on: 16th July 2015 | Updated on: 1st June 2022

Pages

Summary of funding changes

Click on a year below to reveal more information.

Published on: 12th September 2014 | Updated on: 15th April 2024

Pages

Tokens (EPS)

Paper copies that are printed to accompany electronic (EPS) prescriptions are known as ‘tokens’. The barcode on the tokens can be scanned to retrieve the electronic prescription from the central NHS Spine. Community Pharmacy England’s factsheet: Summary of EPS-related forms [...]

Published on: 12th August 2014 | Updated on: 7th March 2023

Pages

Smartcards

Contact your local RA Within this section you will find a summary of the national arrangements for NHS Smartcards, and information about how to administer them. Your local Registration Authority (RA) will manage card issues in your area e.g. providing [...]

Published on: 16th July 2013 | Updated on: 30th January 2024

Pages

Submission (EPS)

EPS endorsing, submission and reconciliation info is set out on this webpage. Click on a heading or link to ‘show’ or read more or return to EPS home or EPS dispensing for more on EPS. Return to the Pharmacy IT hub; [...]

Published on: 16th July 2013 | Updated on: 16th May 2022